Transfer of intracellular HIV Nef to endothelium causes endothelial dysfunction

Indiana University-Purdue University Indianapolis (IUPUI) === With effective antiretroviral therapy (ART), cardiovascular diseases (CVD), are emerging as a major cause of morbidity and death in the aging population with HIV infection. Although this increase in CVD could be partially explained by the...

Full description

Bibliographic Details
Main Author: Wang, Ting
Other Authors: Pelus, Louis
Language:en_US
Published: 2014
Subjects:
Online Access:http://hdl.handle.net/1805/5584
id ndltd-IUPUI-oai-scholarworks.iupui.edu-1805-5584
record_format oai_dc
spelling ndltd-IUPUI-oai-scholarworks.iupui.edu-1805-55842019-05-10T15:21:28Z Transfer of intracellular HIV Nef to endothelium causes endothelial dysfunction Wang, Ting Pelus, Louis Clauss, Matthias A. Yu, Andy Dent, Alexander L. Wek, Ronald C. HIV Nef Endothelial cells MCP-1 apoptosis HIV infections -- Research -- Methodology -- Analysis Cardiovascular system -- Diseases -- Complications HIV infections -- Complications Antiretroviral agents Cardiovascular system -- Diseases -- Epidemiology Endothelial cells -- Research Aging -- Immunological aspects Apoptosis -- Research Protein-protein interactions Molecular association -- Research T cells -- Receptors Monocytes Immunosuppression Virus diseases -- Transmission Indiana University-Purdue University Indianapolis (IUPUI) With effective antiretroviral therapy (ART), cardiovascular diseases (CVD), are emerging as a major cause of morbidity and death in the aging population with HIV infection. Although this increase in CVD could be partially explained by the toxic effects of combined anti-retroviral therapy (ART), more recently, HIV infection has emerged as an independent risk factor for CVD. However, it is unclear how HIV can contribute to CVD in patients on ART, when viral titers are low or non-detectable. Here, we provide several lines of evidence that HIV-Nef, produced in infected cells even when virus production is halted by ART, can lead to endothelial activation and dysfunction, and thus may be involved in CVD. We demonstrate that HIV-infected T cell-induced endothelial cell activation requires direct contact as well as functional HIV-Nef. Nef protein from either HIV-infected or Nef-transfected T cells rapidly transfers to endothelial cells while inducing nanotube-like conduits connecting T cells to endothelial cells. This transfer or transfection of endothelial cells results in endothelial apoptosis, ROS generation and release of monocyte attractant protein-1 (MCP-1). A Nef SH3 binding site mutant abolishes Nef-induced apoptosis and ROS formation and reduces MCP-1 production in endothelial cells, suggesting that the Nef SH3 binding site is critical for Nef effects on endothelial cells. Nef induces apoptosis of endothelial cells through both NADPH oxidase- and ROS-dependent mechanisms, while Nef-induced MCP-1 production is NF-kB dependent. Importantly, Nef can be found in CD4 positive and bystander circulating blood cells in patients receiving virally suppressive ART, and in the endothelium of chimeric SIV-infected macaques. Together, these data indicate that Nef could exert pro-atherogenic effects on the endothelium even when HIV infection is controlled and that inhibition of Nef-associated pathways may be promising new therapeutic targets for reducing the risk for cardiovascular disease in the HIV-infected population.  2014-12-18T19:29:17Z 2014-12-18T19:29:17Z 2014 Thesis http://hdl.handle.net/1805/5584 en_US
collection NDLTD
language en_US
sources NDLTD
topic HIV Nef
Endothelial cells
MCP-1
apoptosis
HIV infections -- Research -- Methodology -- Analysis
Cardiovascular system -- Diseases -- Complications
HIV infections -- Complications
Antiretroviral agents
Cardiovascular system -- Diseases -- Epidemiology
Endothelial cells -- Research
Aging -- Immunological aspects
Apoptosis -- Research
Protein-protein interactions
Molecular association -- Research
T cells -- Receptors
Monocytes
Immunosuppression
Virus diseases -- Transmission
spellingShingle HIV Nef
Endothelial cells
MCP-1
apoptosis
HIV infections -- Research -- Methodology -- Analysis
Cardiovascular system -- Diseases -- Complications
HIV infections -- Complications
Antiretroviral agents
Cardiovascular system -- Diseases -- Epidemiology
Endothelial cells -- Research
Aging -- Immunological aspects
Apoptosis -- Research
Protein-protein interactions
Molecular association -- Research
T cells -- Receptors
Monocytes
Immunosuppression
Virus diseases -- Transmission
Wang, Ting
Transfer of intracellular HIV Nef to endothelium causes endothelial dysfunction
description Indiana University-Purdue University Indianapolis (IUPUI) === With effective antiretroviral therapy (ART), cardiovascular diseases (CVD), are emerging as a major cause of morbidity and death in the aging population with HIV infection. Although this increase in CVD could be partially explained by the toxic effects of combined anti-retroviral therapy (ART), more recently, HIV infection has emerged as an independent risk factor for CVD. However, it is unclear how HIV can contribute to CVD in patients on ART, when viral titers are low or non-detectable. Here, we provide several lines of evidence that HIV-Nef, produced in infected cells even when virus production is halted by ART, can lead to endothelial activation and dysfunction, and thus may be involved in CVD. We demonstrate that HIV-infected T cell-induced endothelial cell activation requires direct contact as well as functional HIV-Nef. Nef protein from either HIV-infected or Nef-transfected T cells rapidly transfers to endothelial cells while inducing nanotube-like conduits connecting T cells to endothelial cells. This transfer or transfection of endothelial cells results in endothelial apoptosis, ROS generation and release of monocyte attractant protein-1 (MCP-1). A Nef SH3 binding site mutant abolishes Nef-induced apoptosis and ROS formation and reduces MCP-1 production in endothelial cells, suggesting that the Nef SH3 binding site is critical for Nef effects on endothelial cells. Nef induces apoptosis of endothelial cells through both NADPH oxidase- and ROS-dependent mechanisms, while Nef-induced MCP-1 production is NF-kB dependent. Importantly, Nef can be found in CD4 positive and bystander circulating blood cells in patients receiving virally suppressive ART, and in the endothelium of chimeric SIV-infected macaques. Together, these data indicate that Nef could exert pro-atherogenic effects on the endothelium even when HIV infection is controlled and that inhibition of Nef-associated pathways may be promising new therapeutic targets for reducing the risk for cardiovascular disease in the HIV-infected population. 
author2 Pelus, Louis
author_facet Pelus, Louis
Wang, Ting
author Wang, Ting
author_sort Wang, Ting
title Transfer of intracellular HIV Nef to endothelium causes endothelial dysfunction
title_short Transfer of intracellular HIV Nef to endothelium causes endothelial dysfunction
title_full Transfer of intracellular HIV Nef to endothelium causes endothelial dysfunction
title_fullStr Transfer of intracellular HIV Nef to endothelium causes endothelial dysfunction
title_full_unstemmed Transfer of intracellular HIV Nef to endothelium causes endothelial dysfunction
title_sort transfer of intracellular hiv nef to endothelium causes endothelial dysfunction
publishDate 2014
url http://hdl.handle.net/1805/5584
work_keys_str_mv AT wangting transferofintracellularhivneftoendotheliumcausesendothelialdysfunction
_version_ 1719080315614396416